Effect of maximum-tolerated doses and low-dose metronomic chemotherapy on serum vascular endothelial growth factor and thrombospondin-1 levels in patients with advanced nonsmall cell lung cancer.

MLA

Tas, Faruk, et al. “Effect of Maximum-Tolerated Doses and Low-Dose Metronomic Chemotherapy on Serum Vascular Endothelial Growth Factor and Thrombospondin-1 Levels in Patients with Advanced Nonsmall Cell Lung Cancer.” Cancer Chemotherapy & Pharmacology, vol. 61, no. 5, Apr. 2008, pp. 721–25. EBSCOhost, https://doi.org/10.1007/s00280-007-0526-4.

APA

Tas, F., Duranyildiz, D., Soydinc, H. O., Cicin, I., Selam, M., Uygun, K., Disci, R., Yasasever, V., & Topuz, E. (2008). Effect of maximum-tolerated doses and low-dose metronomic chemotherapy on serum vascular endothelial growth factor and thrombospondin-1 levels in patients with advanced nonsmall cell lung cancer. Cancer Chemotherapy & Pharmacology, 61(5), 721–725. https://doi.org/10.1007/s00280-007-0526-4

Chicago

Tas, Faruk, Derya Duranyildiz, Hilal O. Soydinc, Irfan Cicin, Meltem Selam, Kazim Uygun, Rian Disci, Vildan Yasasever, and Erkan Topuz. 2008. “Effect of Maximum-Tolerated Doses and Low-Dose Metronomic Chemotherapy on Serum Vascular Endothelial Growth Factor and Thrombospondin-1 Levels in Patients with Advanced Nonsmall Cell Lung Cancer.” Cancer Chemotherapy & Pharmacology 61 (5): 721–25. doi:10.1007/s00280-007-0526-4.